Kidney function and risk of peripheral arterial disease: results from the Atherosclerosis Risk in Communities (ARIC) Study
- PMID: 17215445
- DOI: 10.1681/ASN.2005111204
Kidney function and risk of peripheral arterial disease: results from the Atherosclerosis Risk in Communities (ARIC) Study
Abstract
Chronic kidney disease (CKD) is associated with an increased risk for cardiovascular disease, but its association with peripheral arterial disease (PAD) is unclear. With the use of data from the Atherosclerosis Risk in Communities (ARIC) Study, 14,280 middle-aged adults were categorized on the basis of estimated GFR >/=90, 60 to 89, and 15 to 59 ml/min per 1.73 m(2) for normal kidney function, mildly decreased kidney function, and stages 3 to 4 CKD, respectively. Incident PAD was defined as a new onset of ankle-brachial index <0.9 assessed at regular examinations, new intermittent claudication assessed by annual surveillance, or PAD-related hospital discharges. Incidence rates and relative risks (RR) for PAD were compared across these categories. During a mean follow-up time of 13.1 yr (186,616 person-years), 1016 participants developed PAD. The incidence rates per 1000 person-years were 4.7, 4.9, and 8.6 for the normal kidney function, mildly decreased kidney function, and CKD groups, respectively. Compared with participants with normal kidney function, the age-, gender-, race-, and ARIC field center-adjusted RR for PAD was 1.04 (95% confidence interval [CI] 0.91 to 1.18) for those with mildly decreased kidney function and 1.82 (95% CI 1.34 to 2.47) for those with CKD. After additional adjustment for cardiovascular disease risk factors, an increase in risk for incident PAD still was observed in participants with CKD, with a multivariable adjusted RR of 1.56 (95% CI 1.13 to 2.14). Patients with CKD are at increased risk for incident PAD. Development of strategies for screening and prevention of PAD in this high-risk population seems warranted.
Similar articles
-
Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study.J Am Soc Nephrol. 2005 Feb;16(2):529-38. doi: 10.1681/ASN.2004080656. Epub 2004 Dec 29. J Am Soc Nephrol. 2005. PMID: 15625072
-
Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study.J Am Soc Nephrol. 2007 Apr;18(4):1307-15. doi: 10.1681/ASN.2006101159. Epub 2007 Mar 7. J Am Soc Nephrol. 2007. PMID: 17344421
-
Cardiovascular risk among adults with chronic kidney disease, with or without prior myocardial infarction.J Am Coll Cardiol. 2006 Sep 19;48(6):1183-9. doi: 10.1016/j.jacc.2006.05.047. Epub 2006 Aug 28. J Am Coll Cardiol. 2006. PMID: 16979003
-
Management of peripheral arterial disease in chronic kidney disease.Cardiol Clin. 2005 Aug;23(3):225-36. doi: 10.1016/j.ccl.2005.03.006. Cardiol Clin. 2005. PMID: 16084274 Review.
-
Peripheral arterial disease in patients with diabetes.J Am Coll Cardiol. 2006 Mar 7;47(5):921-9. doi: 10.1016/j.jacc.2005.09.065. Epub 2006 Feb 9. J Am Coll Cardiol. 2006. PMID: 16516072 Review.
Cited by
-
Pre-operative ankle-brachial index for cardiovascular risk assessment in simultaneous pancreas-kidney transplant recipients: a simple and elegant strategy!BMC Surg. 2021 Mar 22;21(1):156. doi: 10.1186/s12893-021-01159-6. BMC Surg. 2021. PMID: 33752640 Free PMC article.
-
Psychosocial factors and subsequent risk of hospitalizations with peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) Study.Atherosclerosis. 2021 Jul;329:36-43. doi: 10.1016/j.atherosclerosis.2021.04.020. Epub 2021 May 9. Atherosclerosis. 2021. PMID: 34020783 Free PMC article.
-
Physical Activity and Subsequent Risk of Hospitalization With Peripheral Artery Disease and Critical Limb Ischemia in the ARIC Study.J Am Heart Assoc. 2019 Nov 5;8(21):e013534. doi: 10.1161/JAHA.119.013534. Epub 2019 Oct 23. J Am Heart Assoc. 2019. PMID: 31642360 Free PMC article.
-
Positive Correlation of Serum Resistin Level with Peripheral Artery Disease in Patients with Chronic Kidney Disease Stage 3 to 5.Int J Environ Res Public Health. 2021 Dec 3;18(23):12746. doi: 10.3390/ijerph182312746. Int J Environ Res Public Health. 2021. PMID: 34886472 Free PMC article.
-
High Fibroblast Growth Factor 23 concentrations in experimental renal failure impair calcium handling in cardiomyocytes.Physiol Rep. 2018 Apr;6(7):e13591. doi: 10.14814/phy2.13591. Physiol Rep. 2018. PMID: 29611320 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases